University of Minnesota. Driven to Discover.
The PATH Act would establish a new "limited population antibacterial drug approval pathway."
Hospital-acquired and ventilator-related pneumonia get a 7-day course, IDSA says.
The Obama administration unveils a plan for addressing the threat in the next 5 years.
Response to seasonal flu, H7N9, MERS, and other threats could be markedly diminished.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.